Champions Oncology Earnings
NASDAQ: CSBRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
4.79-0.02 (-0.42%)
At close: Oct 15, 4:00 PM ET · Delayed 15 min
Champions Oncology earnings summary
In its most recent report on Sep 10, 2026 (Q1 2027), CSBR posted EPS of $-0.03. Revenue for the quarter was $15.2 million. Across the last 16 reports, CSBR shares moved an average of 5.2% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
CSBR earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Sep 10, 2026 | — | $-0.03 | — | +3.9% |
| Jul 27, 2026 | — | $-0.05 | — | -3.2% |
| Mar 12, 2026 | — | $-0.02 | — | -3.9% |
| Dec 15, 2025 | — | $0.02 | — | -3.3% |
| Sep 15, 2025 | — | $-0.03 | — | -4.1% |
| Jul 23, 2025 | — | $-0.12 | — | -1.3% |
| Mar 11, 2025 | — | $0.31 | — | +3.8% |
| Dec 11, 2024 | — | $0.05 | — | +18.6% |
| Sep 11, 2024 | — | $0.09 | — | -5.5% |
| Jul 18, 2024 | — | $-0.01 | — | -3.0% |
| Mar 12, 2024 | — | $-0.19 | — | -1.3% |
| Dec 12, 2023 | — | $-0.15 | — | +8.7% |
| Sep 13, 2023 | — | $-0.19 | — | +2.9% |
| Jul 24, 2023 | — | $-0.19 | — | -3.7% |
| Mar 15, 2023 | — | $-0.18 | — | +6.7% |
| Dec 13, 2022 | — | $0.00 | — | -8.6% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.